AUSTIN - Key Persons
David has extensive litigation, patent prosecution and intellectual property counselling experience. In litigation, he has represented clients in numerous ANDA and biosimilar litigations, polymer litigations, as well as litigations involving trade secret misappropriation, technology licenses and contract disputes. David has also prosecuted patents, performed freedom-to-operate and opinion work, and inter partes reviews in the fields of chemistry, medicinal chemistry, polymers, small-molecule drugs, antibodies and biosimilars, as well as a variety of additional technologies.
David has a Ph.D. in organic chemistry with deep experience in biotechnology. Prior to becoming an attorney, David was a professor in the Chemistry Department at Yale University where his laboratory developed a novel phage-display drug discovery platform upon which he co-founded Ambit Biosciences. He also served as Director of Medicinal Chemistry at Rib-X Pharmaceuticals (now Melinta Therapeutics). David's experience in both academia and industry provide him with a unique ability to understand and meet a client's needs.